Minimal residual disease monitoring in childhood acute lymphoblastic leukemiaCAMPANA, Dario.Current opinion in hematology. 2012, Vol 19, Num 4, pp 313-318, issn 1065-6251, 6 p.Article

Determination of minimal residual disease in leukaemia patientsCAMPANA, Dario.British journal of haematology. 2003, Vol 121, Num 6, pp 823-838, issn 0007-1048, 16 p.Article

Status of minimal residual disease testing in childhood haematological malignanciesCAMPANA, Dario.British journal of haematology. 2008, Vol 143, Num 4, pp 481-489, issn 0007-1048, 9 p.Article

Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantationCAMPANA, Dario; WING LEUNG.British journal of haematology. 2013, Vol 162, Num 2, pp 147-161, issn 0007-1048, 15 p.Article

Minimal Residual Disease in Acute Lymphoblastic LeukemiaCAMPANA, Dario.Seminars in hematology. 2009, Vol 46, Num 1, pp 100-106, issn 0037-1963, 7 p.Article

Immunophenotyping of leukemiaCAMPANA, Dario; BEHM, Frederick G.Journal of immunological methods. 2000, Vol 243, Num 1-2, pp 59-75, issn 0022-1759Article

Role of Minimal Residual Disease Monitoring in Adult and Pediatric Acute Lymphoblastic LeukemiaCAMPANA, Dario.Hematology/oncology clinics of North America. 2009, Vol 23, Num 5, issn 0889-8588, vii, 1083-1098 [16 p.]Article

Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cellsIMAI, Chihaya; IWAMOTO, Shotaro; CAMPANA, Dario et al.Blood. 2005, Vol 106, Num 1, pp 376-383, issn 0006-4971, 8 p.Article

Minimal residual disease detection in acute lymphoblastic leukemia: Real improvement with the real-time quantitative PCR method?NEALE, Geoffrey A. M; CAMPANA, Dario; PUI, Ching-Hon et al.Journal of pediatric hematology/oncology. 2003, Vol 25, Num 2, pp 100-102, issn 1077-4114, 3 p.Article

Advances in the immunological monitoring of childhood acute lymphoblastic leukaemiaCAMPANA, Dario; COUSTAN-SMITH, Elaine.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 1, pp 1-19, issn 1521-6926Article

A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor CellsCHANG, Yu-Hsiang; CONNOLLY, John; SHIMASAKI, Noriko et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 6, pp 1777-1786, issn 0008-5472, 10 p.Article

Replicative potential of human natural killer cellsFUJISAKI, Hiroyuki; KAKUDA, Harumi; IMAI, Chihaya et al.British journal of haematology. 2009, Vol 145, Num 5, pp 606-613, issn 0007-1048, 8 p.Article

Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid TumorsCHO, Duck; SHOOK, David R; SHIMASAKI, Noriko et al.Clinical cancer research (Print). 2010, Vol 16, Num 15, pp 3901-3909, issn 1078-0432, 9 p.Article

FLT3 inhibition selectively kills childhood acute lymphoblastic leukemia cells with high levels of FLT3 expressionBROWN, Patrick; LEVIS, Mark; SHURTLEFF, Sheila et al.Blood. 2005, Vol 105, Num 2, pp 812-820, issn 0006-4971, 9 p.Article

Characterization of CD34⁺, CD13⁺, CD33-cells, a rare subset of immature human hematopoietic cellsGAIPA, Giuseppe; COUSTAN-SMITH, Elaine; TODISCO, Elisabetta et al.Haematologica (Roma). 2002, Vol 87, Num 4, pp 347-356, issn 0390-6078Article

Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemiaFAHAM, Malek; JIANBIAO ZHENG; MOORHEAD, Martin et al.Blood. 2012, Vol 120, Num 26, pp 5173-5180, issn 0006-4971, 8 p.Article

Effect of Body Mass Index on the Outcome of Children With Acute Myeloid LeukemiaINABA, Hiroto; SURPRISE, Harriet C; CAMPANA, Dario et al.Cancer. 2012, Vol 118, Num 23, pp 5989-5996, issn 0008-543X, 8 p.Article

Treatment Outcome in Older Patients With Childhood Acute Myeloid LeukemiaRUBNITZ, Jeffrey E; POUNDS, Stanley; INABA, Hiroto et al.Cancer. 2012, Vol 118, Num 24, pp 6253-6259, issn 0008-543X, 7 p.Article

High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemiaWING LEUNG; CAMPANA, Dario; HARTFORD, Christine et al.Blood. 2011, Vol 118, Num 2, pp 223-230, issn 0006-4971, 8 p.Article

Phase II Study of Topotecan in Combination With Dexamethasone, Asparaginase, and Vincristine in Pediatric Patients With Acute Lymphoblastic Leukemia in First RelapseHIJIYA, Nobuko; STEWART, Clinton F; YINMEI ZHOU et al.Cancer. 2008, Vol 112, Num 9, pp 1983-1991, issn 0008-543X, 9 p.Article

Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemiaJIANN-SHIUH CHEN; COUSTAN-SMITH, Elaine; TOSHIO SUZUKI et al.Blood. 2001, Vol 97, Num 7, pp 2115-2120, issn 0006-4971Article

Definition of Cure in Childhood Acute Myeloid LeukemiaRUBNITZ, Jeffrey E; INABA, Hiroto; LEUNG, Wing H et al.Cancer. 2014, Vol 120, Num 16, pp 2490-2496, issn 0008-543X, 7 p.Article

Impact of Tyrosine Kinase Inhibitors on Minimal Residual Disease and Outcome in Childhood Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaJEHA, Sima; COUSTAN-SMITH, Elaine; CHOI, John K et al.Cancer. 2014, Vol 120, Num 10, pp 1514-1519, issn 0008-543X, 6 p.Article

Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemiaYANG, Jun J; CHENG CHENG; BOROWITZ, Michael J et al.Blood. 2012, Vol 120, Num 20, pp 4197-4204, issn 0006-4971, 8 p.Article

New markers for minimal residual disease detection in acute lymphoblastic leukemiaCOUSTAN-SMITH, Elaine; GUANGCHUN SONG; DOWNING, James R et al.Blood. 2011, Vol 117, Num 23, pp 6267-6276, issn 0006-4971, 10 p.Article